Project Description
Tumor infiltrating lymphocytes or TILs are immune system cells that have penetrated the tumor. Tailored’s technology leverages proprietary next generation methods to identify tumor-reactive T-cells and therefore develop a cell therapy product comprised of the best tumor fighters. Advanced genomics and single cell analysis capabilities have produced important insights into proprietary markers and genomic signature characteristic of tumor-fighting T-cells found within TIL.
